Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study
Tomography · 17.11.2026 · 12 (11) · 165
DOI: 10.3390/tomography12110165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, online erschienen am 17.11.2026. Verfasst von Jian Chen und 6 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Fujian Provincial Health Technology Project.
Abstract (Originalsprache)
Background
Neuroendocrine carcinoma of the cervix (NECC) is a rare malignancy, and pretreatment overall survival (OS) assessment remains limited. We developed and externally validated an MRI radiomics model for OS risk stratification.
Methods
This retrospective study included 128 patients: Center 1 served as the development cohort (n = 90), and Center 2 as the independent external validation cohort (n = 38). The model was selected using development data and locked before validation. Evaluation included Harrell C-index, inverse-probability-of-censoring-weighted (IPCW) AUC, calibration, Brier score, decision-curve analysis, and survival stratification.
Results
The model comprised three intratumoral T2-weighted imaging features fitted using CoxBoost 1.5.2. Its external C-index was 0.737 (95% CI, 0.615–0.850), compared with 0.633 (95% CI, 0.523–0.749) for the revised clinical model; the paired difference was 0.104 (95% CI, −0.018 to 0.226). A nested sensitivity analysis of the automated selection procedure yielded a mean C-index of 0.592 (SD, 0.049). IPCW AUCs were 0.741 (95% CI, 0.562–0.891) at 3 years and 0.763 (95% CI, 0.583–0.919) at 5 years. At 3 and 5 years, calibration intercepts were 0.03 and −0.09, slopes 1.14 and 1.20, and Brier scores 0.202 and 0.195, respectively. Exploratory decision-curve analysis suggested potential net benefit over selected thresholds. Hazard ratios (HRs; 95% CIs) for high versus low risk were 1.96 (1.06–3.62) and 3.61 (1.39–9.38) in the development and external cohorts, respectively. Corresponding HRs per development-cohort SD increase in the score were 1.83 (1.29–2.60) and 2.42 (1.45–4.04).
Conclusions
The pretreatment MRI radiomics model showed external prognostic discrimination for OS in NECC, but superiority over the pretreatment clinical model was not demonstrated. Further independent validation is needed.
Förderung
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Technology Project
Zitieren
APA
Chen, J., Jiang, F., Chen, X., Lin, R., Ma, N., Yu, H., & Sun, Y. (2026). Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study. Tomography, 12(11), 165. https://doi.org/10.3390/tomography12110165
Vancouver
Chen J, Jiang F, Chen X, Lin R, Ma N, Yu H, et al. Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study. Tomography. 2026;12(11):165. doi:10.3390/tomography12110165
BibTeX
@article{Chen2026,
author = {Chen, Jian and Jiang, Fengle and Chen, Xingfa and Lin, Rong and Ma, Ning and Yu, Haijuan and Sun, Yang},
title = {Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study},
journal = {Tomography},
year = {2026},
volume = {12},
number = {11},
pages = {165},
doi = {10.3390/tomography12110165}
}
EUVIMED